Carcinoma, Ductal, Breast clinical trials at UC Health
1 research study open to eligible people

• Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

  open to eligible females ages 18 years and up

  Phase 2, open-label study of AVB-620 in women with primary, nonrecurrent and nonmetastatic breast cancer undergoing surgery.

  at UCSD

Last updated: November 19, 2019